| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |